Alexander St. John

Dr. Alexander St. John

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2015 in Science Advances
Verified
Journal Article
Open access
PDF file
JBJames R. Baylis
James R. Baylis
JYJu Hun Yeon
Ju Hun Yeon
MTMax H. Thomson
Max H. Thomson
AKAmir Kazerooni
Amir Kazerooni
XWXu Wang
Xu Wang
CKChristian J. Kastrup
Christian J. Kastrup
Simple, water-reactive particles can carry enzymes upstream through aqueous solutions and into wounds to halt severe bleeding.

13 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
LTLucas H. Ting
Lucas H. Ting
SFShirin Feghhi
Shirin Feghhi
NTNikita Taparia
Nikita Taparia
ASAnnie O. Smith
Annie O. Smith
AKAri Karchin
Ari Karchin
NSNathan Sniadecki
Nathan Sniadecki
Platelets contract forcefully after their activation, contributing to the strength and stability of platelet aggregates and fibrin clots during blood coagulation. Viscoelastic approaches can be used to assess platelet-induced clot strengthening, but they require thrombin and fibrin generation and are unable to measure platelet forces directly. Here, we report a rapid, microfluidic approach for measuring the contractile force of platelet aggregates for the detection of platelet dysfunction. We find that platelet forces are significantly reduced when blood samples are treated with inhibitors of myosin, GPIb-IX-V, integrin αIIbβ3, P2Y12, or thromboxane generation. Clinically, we find that platelet forces are measurably lower in cardiology patients taking aspirin. We also find that measuring platelet forces can identify Emergency Department trauma patients who subsequently require blood transfusions. Together, these findings indicate that microfluidic quantification of platelet forces may be a rapid and useful approach for monitoring both antiplatelet therapy and traumatic bleeding risk.

1 July 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
NWNathan J. White
Nathan J. White
YWYi Wang
Yi Wang
XFXiaoyun Fu
Xiaoyun Fu
JCJessica C. Cardenas
Jessica C. Cardenas
EMErika J. Martin
Erika J. Martin
DCDominic Chung
Dominic Chung

15 October 2013 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
LDLawrence A. DeLuca
Lawrence A. DeLuca
AJAlexander St. John
Alexander St. John
USUwe Stolz
Uwe Stolz
LMLincoln Matheson
Lincoln Matheson
ASAllan Simpson
Allan Simpson
KDKurt R. Denninghoff
Kurt R. Denninghoff
Background: Hirsch's h‐index (h) attempts to measure the combined academic impact and productivity of a scientist by counting the number of publications by an author, ranked in descending order by number of citations, until the paper number equals the number of citations. This approach provides a natural number or index of the number of publications and the number of citations per publication. H was first described in physics and was demonstrated to be highly predictive of continued academic activity, including recognized measures of scientific excellence such as membership in the National Academy of Sciences and being a Nobel laureate. Citation rates, research environments, and years of experience all affect h, making any comparisons appropriate only for scientists working in the same field for a similar time period. The authors are unaware of any report describing the distribution of h among academic emergency physicians (AEPs).Objectives: The objective was to describe the distribution of h for AEPs and to determine whether Hirsch's demonstration of the h‐index as a predictor of continued scholarly activity among physicists would also apply to AEPs.Methods: Academic EPs were identified from lists provided on allopathic U.S. emergency medicine (EM) residency program websites. “Harzing's Publish or Perish,” a free program available on the Web that queries Google Scholar, was used to calculate h for each AEP. Agreement between raters was analyzed on a subset of 100 EPs. An analysis of the 20 EPs with the top h‐indices was performed to characterize the entire body of their scholarly work, and their h‐indices were calculated at 12 and 24 years into their careers.Results: A total of 4,744 AEPs from 136 programs were evaluated. Nine programs did not publicly list the faculty at their institutions and were excluded. A linear weighted kappa was used to measure rater concordance, with agreement of 98.3% and κ = 0.92 (95% confidence interval [CI] = 0.861 to 0.957). The majority of AEPs had h‐indices of zero or one (59%), 85% had h‐indices less than six, 95% less than 13, and 99% less than 24. Ten percent of AEPs had h/(years in publication) of 0.5 or greater. For the top 20 EPs, the mean (± standard deviation [±SD]) h‐index increased from 7.6 (±4.6) to 23.5 (±9.4) between years 12 and 24. The mean (±SD) increase in h‐index was 15.8 (±7.6).Conclusions: The h‐index can be used to characterize the academic productivity of AEPs. An h/year of 0.5 or greater is characteristic of the most productive EPs and represents only 10% of all AEPs. The 12‐year h‐index of top‐performing EPs was strongly related to their future academic productivity. The distribution of h among EPs may provide a means for individual investigators and academic leaders to evaluate performance and identify EPs with future success in EM research.

6 December 2018 in Blood
Verified
Journal Article
Closed access
PDF file
JMJessica Morales-Ortíz
Jessica Morales-Ortíz
VDVictoria Deal
Victoria Deal
FRFiorella Reyes
Fiorella Reyes
Gerónimo Maldonado-MartínezGerónimo Maldonado-Martínez
Gerónimo Maldonado-Martínez
NLNahomy Ledesma
Nahomy Ledesma
A. Valance WashingtonA. Valance Washington
A. Valance Washington
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) affect >200 000 individuals yearly with a 40% mortality rate. Although platelets are implicated in the progression of ALI/ARDS, their exact role remains undefined. Triggering receptor expressed in myeloid cells (TREM)–like transcript 1 (TLT-1) is found on platelets, binds fibrinogen, and mediates clot formation. We hypothesized that platelets use TLT-1 to manage the progression of ALI/ARDS. Here we retrospectively measure plasma levels of soluble TLT-1 (sTLT-1) from the ARDS Network clinical trial and show that patients whose sTLT-1 levels were >1200 pg/mL had nearly twice the mortality risk as those with <1200 pg/mL (P < .001). After correcting for confounding factors such as creatinine levels, Acute Physiology And Chronic Health Evaluation III scores, age, platelet counts, and ventilation volume, sTLT-1 remains significant, suggesting that sTLT-1 is an independent prognostic factor (P < .0001). These data point to a role for TLT-1 during the progression of ALI/ARDS. We use a murine lipopolysaccharide-induced ALI model and demonstrate increased alveolar bleeding, aberrant neutrophil transmigration and accumulation associated with decreased fibrinogen deposition, and increased pulmonary tissue damage in the absence of TLT-1. The loss of TLT-1 resulted in an increased proportion of platelet-neutrophil conjugates (43.73 ± 24.75% vs 8.92 ± 2.4% in wild-type mice), which correlated with increased neutrophil death. Infusion of sTLT-1 restores normal fibrinogen deposition and reduces pulmonary hemorrhage by 40% (P ≤ .001) and tissue damage by 25% (P ≤ .001) in vivo. Our findings suggest that TLT-1 uses fibrinogen to govern the transition between inflammation and hemostasis and facilitate controlled leukocyte transmigration during the progression of ARDS.

19 February 2019 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
AJAlexander St. John
Alexander St. John
JNJason C. Newton
Jason C. Newton
EMErika J. Martin
Erika J. Martin
BMBassem Mohammed
Bassem Mohammed
DCDaniel Contaifer
Daniel Contaifer
NWNathan J. White
Nathan J. White